Dandio, Ricky G.
HRN: 22-47-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/09/2023
01/16/2023
IV
300mg
Q6h
Ulcerations
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes